Related Experiment Video

Updated: Aug 22, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experience

Warren J Cantor1, James E Tcheng, James C Blankenship

  • 1St. Michael's Hospital, Division of Cardiology, 30 Bond Street, Toronto, Ontario, Canada, M44-1W8. cantorw@smh.toronto.on.ca

The Journal of Invasive Cardiology
|September 9, 2004
PubMed

Insights

Most ischemic complications after percutaneous coronary intervention occur within 24 hours, peaking at 12-18 hours. Glycoprotein IIb/IIIa inhibitors effectively reduce these early risks.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) is a common procedure for coronary artery disease.
  • Ischemic complications following PCI can lead to significant morbidity and mortality.
  • Understanding the timing and risk factors for these complications is crucial for patient management.

Purpose of the Study:

  • To determine the timing of ischemic complications within 30 days after PCI.
  • To analyze the risk of complications in relation to time post-randomization.
  • To evaluate the role of glycoprotein IIb/IIIa inhibitors in mitigating early ischemic events.

Main Methods:

  • Analysis of data from the Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) trial.
  • Inclusion of patients undergoing PCI.
  • Assessment of ischemic complications (death, myocardial infarction, target vessel revascularization) within 30 days.

Main Results:

  • 8.6% of patients (178/2064) experienced ischemic complications within 30 days.
  • Over 85% of complications occurred within 24 hours post-randomization, with the highest risk between 12-18 hours.
  • 31% of patients with myocardial infarction (MI) within 24 hours had normal CK-MB at 6 hours.
  • No rebound increase in events after eptifibatide cessation; treatment benefit persisted to 30 days.

Conclusions:

  • Ischemic complications after PCI are concentrated in the early post-procedural period, particularly within the first 24 hours.
  • Myocardial infarction may not be immediately evident by standard biomarker measurements (CK-MB) at 6 hours.
  • Glycoprotein IIb/IIIa inhibitors represent a key modifiable factor in reducing the risk of early ischemic complications following PCI.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...